Related Experiment Video
Updated: Apr 20, 2026
Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
Published on: April 14, 2026
Surgical outcomes of Baerveldt implants in pediatric glaucoma patients
Audrey Xi Tai1, Jonathan C Song2
1Ross Eye Institute, University at Buffalo, The State University of New York, Buffalo, New York.
Insights
The Baerveldt glaucoma implant (BGI) effectively lowers intraocular pressure (IOP) in pediatric glaucoma patients. This surgical intervention demonstrated a high success rate in reducing IOP for children with refractory glaucoma.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Pediatric Glaucoma Management
Background:
- Pediatric glaucoma presents unique challenges in intraocular pressure (IOP) management.
- Refractory glaucoma in children often requires advanced surgical interventions.
Purpose of the Study:
- To assess the efficacy of the Baerveldt glaucoma implant (BGI) in pediatric patients.
- Evaluate the long-term outcomes of BGI surgery for childhood glaucoma.
Main Methods:
- Retrospective review of pediatric glaucoma patients (5 months to 19 years) who underwent BGI implantation.
- Surgical success defined by IOP >6 mm Hg and <21 mm Hg, without complications or further surgery.
- Postoperative evaluations at 3-9, 12-18, and 24-30 months.
Main Results:
- Mean preoperative IOP was 31.6 mm Hg, reduced to 16.3-19.5 mm Hg postoperatively.
- Cumulative success probability reached 93.3% at 3-9 months and 86.7% at 12-30 months.
- Six eyes experienced failure within 30 months due to uncontrolled IOP, device replacement, or vision loss.
Conclusions:
- Baerveldt glaucoma implant surgery is an effective treatment for reducing IOP in pediatric refractory glaucoma.
- BGI provides a viable surgical option for managing complex pediatric glaucoma cases.
- Sustained IOP reduction and high success rates observed in the pediatric cohort.
Purpose:
To evaluate the efficacy of the Baerveldt glaucoma implant (BGI) in children.
Methods:
The medical records of pediatric glaucoma patients aged 5 months to 19 years who underwent BGI placement by a single surgeon (JCS) between January 1, 2000, and March 1, 2010, were retrospectively reviewed. Patients were evaluated at 3-9 months, 12-18 months, and 24-30 months after surgery. We defined surgical success as a postoperative intraocular pressure (IOP) of >6 mm Hg and <21 mm Hg, without additional glaucoma surgery, loss of light perception, removal of the BGI, chronic hypotony, retinal detachment, malignant glaucoma, endophthalmitis, or phthisis bulbi. Additional outcome measures were tube erosion, corneal decompensation, tube retraction, visual acuity, clinical bleb encapsulation, and choroidal detachment.
Results:
A total of 45 eyes of 36 patients were included. The mean preoperative IOP was 31.6 ± 5.0 mm Hg; the mean postoperative IOP, 16.3 ± 5.1 mm Hg at 3-9 months, 19.5 ± 4.8 mm Hg at 12-18 months, and 18.3 ± 4.8 mm Hg at 24-30 months. Cumulative probability of success was 93.3% at 3-9 months, 86.7% at 12-18 months, and 86.7% at 24-30 months. Overall, 6 eyes failed within 30 months because of uncontrolled IOP (3 eyes), replacement of the glaucoma drainage device (2 eyes), and no light perception (1 eye).
Conclusions:
In this study cohort, BGI surgery effectively reduced IOP in pediatric patients with refractory glaucoma.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment